Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

December 31, 2002

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Selegiline

Trial Locations (16)

21201

VA Maryland Healthcare System, Baltimore

45220

Cincinnati VA Medical Center, Cincinnati

48207

Wayne State University, Detroit

70112

New Orleans VA Medical Center, New Orleans

75216

VA North Texas Health Care System, Dallas

77030

University of Texas Hlth Sci Ctr Houston, Houston

80220

Denver VA Medical Center, Denver

84148

Salt Lake City VA Medical Center, Salt Lake City

85723

Tucson VA Medical Center, Tucson

90025

Friends Research Institute-2, Los Angeles

Friends Research Institute, Los Angeles

94110

San Francisco General Hosptial, San Francisco

94121

San Francisco VA Medical Center, San Francisco

94704

Haight-Ashbury Free Clinic, Berkeley

98108

VA Puget Sound Health Care System, Seattle

29425 742

Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Somerset Pharmaceuticals

INDUSTRY

lead

National Institute on Drug Abuse (NIDA)

NIH